mHTT-Targeted PROTAC Protein Degrader Program (Arvinas)

N/A

Report date: 2025/01/26 17:11:28
NME

Base Information

Drug NamemHTT-Targeted PROTAC Protein Degrader Program (Arvinas)
Drug Alias Namemutant huntingtin protein inhibitor (Arvinas)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHuntingtin inhibitors
TargetsHuntingtin
Therapy Area/IndicationsHuntington Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesArvinas Inc
China Registration ClassN/A

Develop Information

Active CompaniesArvinas Inc
Inactive CompaniesN/A
Active IndicationsHuntington Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A